Lazier Racing Partners Teams Up with DarioHealth for the Indy 500
Indy 500 sponsorship deal thrusts diabetes awareness into the driver's seat
CAESAREA, Israel and INDIANAPOLIS, May 24, 2017 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that it is partnering with Lazier Racing Partners and driver Buddy Lazier to raise diabetes awareness at the 101st Indianapolis 500 presented by PennGrade Motor Oil, which is set to take place on Sunday, May 28th at the famed Indianapolis Motor Speedway.
The Indianapolis Motor Speedway, also known as "The Brickyard" by racing enthusiasts, has upwards of 450,000 guests on race day along with a worldwide television audience of millions. The partnership is the brainchild of Lazier Racing Partners' sponsorship developer Bruce Bohlander, who personally uses Dario to manage his diabetes, and wants to use the Indy 500 as a platform to raise diabetes awareness. As part of the agreement, DarioHealth's logo will prominently appear on Buddy Lazier's #44 car and on the team's official uniform.
The 1996 Indy 500 winner and 2000 IndyCar Champion, Lazier is among the most experienced racers in the field, and at age 49, he is making his 20th career Indy 500 start. Should Lazier win, he would become the oldest winner in history, passing Al Unser's 1978 Indy 500 win at the age of 47.
The acclaimed Dario™ Blood Glucose Monitoring System all-in-one blood glucose meter and native smartphone app provides people with diabetes and pre-diabetes with a unique method to check their blood glucose levels via their iPhone.
Buddy Lazier said, "DarioHealth has a unique and easy solution for diabetes management. The Dario™ Blood Glucose Monitoring System is an all-in-one blood glucose meter that connects to an iPhone. It's a truly amazing product and we hope to raise awareness about diabetes, which is one of the biggest chronic diseases our country is facing today."
Erez Raphael, Chairman and CEO of DarioHealth, commented about the sponsorship, "Buddy Lazier is one of the most well-respected names in auto racing today. He is a past Indianapolis 500 winner and shows remarkable dedication to his sport. People with diabetes can learn from him that determination and commitment can lead to better health outcomes. Our new relationship with the Lazier Family is the vision of one our users, Mr. Bruce Bohlander, and we are grateful for his continued support and incredible feedback."
The company will be running a special $44 introductory offer in honor of Buddy Lazier's car number. For more information about this offer, visit http://www.mydario.com/.
About DarioHealth Corp.
DarioHealth Corp. is a leading global digital health company serving tens of thousands of users with dynamic mobile health solutions. We believe people deserve the best tools to manage their treatment, and harnessing big data, we have developed a unique way for our users to analyze and personalize their diabetes management. With our smart diabetes solution, users have direct access to track and monitor all facets of diabetes, without having the disease slow them down. The acclaimed Dario™ Blood Glucose Monitoring System all-in-one blood glucose meter and native smartphone app gives users an unrivaled method for self-diabetes management. DarioHealth is headquartered in Caesarea, Israel with a regional office in Burlington, Massachusetts. For more information, visit http://mydario.investorroom.com/.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and partners of DarioHealth Corp. (the "Company") related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate," or "continue" are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results (including, without limitation, the timing for and results of the Company's commercial and regulatory plans for Dario™) may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
Lazier Racing Partners Media Contact
Bruce Bohlander
[email protected]
317-979-7061
DarioHealth Corporate and Media Contact
Shmuel Herschberg
Marketing Director
[email protected]
1-800-896-9062
DarioHealth Investor Relations Contact
Hayden IR
Rob Fink / Brett Maas
[email protected]
646-415-8972 / 646-536-7331
SOURCE DarioHealth Corp.
Share this article